
Validea's guru fundamental report assigns Lam Research Corp (LRCX), a large-cap semiconductor growth stock, a 100% rating under its Warren Buffett-inspired Patient Investor model. This top rating signifies LRCX's strong alignment with the strategy's criteria for predictable profitability, low debt, and reasonable valuation, passing all fundamental tests including earnings predictability, free cash flow, and return on equity. The assessment highlights LRCX's compelling fundamental appeal for value-oriented investors.
Lam Research Corp (LRCX) has received a maximum 100% rating from Validea's Patient Investor model, which is based on the investment principles of Warren Buffett. This score indicates an exceptionally strong alignment with the strategy's focus on companies with predictable long-term profitability, low debt, and reasonable valuations. According to the report, LRCX passed all of the model's fundamental tests, including key criteria such as Earnings Predictability, Debt Service, Return on Equity, Free Cash Flow, and Share Repurchase. The perfect score for a large-cap growth stock within the competitive semiconductor industry suggests a rare combination of strong growth characteristics and robust value-oriented fundamentals, a profile that strongly appeals to quality-focused investors.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.85
Ticker Sentiment